Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 15;14(10):1016.
doi: 10.3390/diagnostics14101016.

Vasa Previa and the Role of Fetal Fibronectin and Cervical Length Surveillance: A Review

Affiliations
Review

Vasa Previa and the Role of Fetal Fibronectin and Cervical Length Surveillance: A Review

Antonia F Oladipo et al. Diagnostics (Basel). .

Abstract

Vasa previa is a pregnancy complication that occurs when unprotected fetal blood vessels traverse the cervical os, placing the fetus at high risk of exsanguination and fetal death. These fetal vessels may be compromised by fetal movement and compression, leading to poor oxygen distribution and asphyxiation. Diagnostic tools for vasa previa management and preterm labor (PTL) include transvaginal ultrasound, cervical length (CL) surveillance and use of fetal fibronectin (FFN) testing. These tools can prove to be quite useful as they allow for lead time in the prediction of PTL and spontaneous rupture of membranes which can result in devastating outcomes for pregnancies affected by vasa previa. We conducted a literature review on vasa previa management and the usefulness of FFN and CL surveillance in predicting PTL and found 36 related papers. Although there is limited research available to show the impact of FFN and CL surveillance in the management of vasa previa, there is sufficient evidence to support FFN and CL surveillance in predicting the onset of PTL, which can have devastating consequences for the pregnancies affected. It can be extrapolated that these tools, by helping to determine pregnancies at risk for PTL, could improve management and outcomes in patients with vasa previa. Future studies investigating the management of vasa previa with FFN and CL surveillance to reduce the burden of PTL and its associated comorbidities are warranted.

Keywords: cervical length; fetal fibronectin; prenatal diagnosis; preterm birth; vasa previa.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Color Doppler demonstrating fetal vessels over the cervix. Silver, Placenta Previa, Vasa Previa and Placenta Accreta. Obstet. Gynecol. 2015 [13].

Similar articles

References

    1. Rao K.P., Belogolovkin V., Yankowitz J., Spinnato J.A. Abnormal placentation: Evidence-based diagnosis and management of placenta previa, placenta accreta, and vasa previa. Obstet. Gynecol. Surv. 2012;67:503–519. doi: 10.1097/OGX.0b013e3182685870. - DOI - PubMed
    1. Jauniaux E., Melcer Y., Maymon R. Prenatal diagnosis and management of vasa previa in twin pregnancies: A case series and systematic review. Am. J. Obstet. Gynecol. 2017;216:568–575. doi: 10.1016/j.ajog.2017.01.029. - DOI - PubMed
    1. Son M., Miller E.S. Predicting preterm birth: Cervical length and fetal fibronectin. Semin. Perinatol. 2017;41:445–451. doi: 10.1053/j.semperi.2017.08.002. - DOI - PMC - PubMed
    1. Buchanan-Hughes A., Bobrowska A., Visintin C., Attilakos G., Marshall J. Velamentous cord insertion: Results from a rapid review of incidence, risk factors, adverse outcomes and screening. Syst. Rev. 2020;9:147. doi: 10.1186/s13643-020-01355-0. - DOI - PMC - PubMed
    1. Yeaton-Massey A., Girsen A.I., Mayo J.A., Blumenfeld Y.J., El-Sayed Y.Y., Stevenson D.K., Shaw G.M. Vasa previa and extreme prematurity: A population-based study. J. Perinatol. Off. J. Calif. Perinat. Assoc. 2019;39:475–480. doi: 10.1038/s41372-019-0319-8. - DOI - PubMed

LinkOut - more resources